This is a service of EIN News a digital news provider
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Ranbaxy News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Ranbaxy News

Sort by: relevance (24 hours) relevance date
  • Dr Reddy's files for marketing Lipitor generic 7 Nov 2009 06:45 GMT
    ... drug, with global sales of $8.3 billion in the last nine months. So far, Ranbaxy ( ) is the only other Indian drugmaker to develop a generic for the ...

  • Sensex Gains 94.38 Pts; Nifty Up By 30.6 Pts 7 Nov 2009 07:17 GMT
    ... 4730 & 4700. Sector specific, pharma, auto and technology look very strong. In pharma, Ranbaxy, Dr. Reddy's Laboratories are attractive while Tata Motors & M&M are best bets in ...

  • Dr Reddy's files for marketing 7 Nov 2009 07:51 GMT
    ... drug, with global sales of $8.3 billion in the last nine months. So far, Ranbaxy is the only other Indian drugmaker to develop a generic for the drug, whose ...

  • Cholesterol drug sales set to double 7 Nov 2009 02:55 GMT
    ... about Rs 1,000 crore, growing at a single digit rate per annum. Companies like Ranbaxy, Biocon, Cipla and Orchid produce generic versions. Sarabjit Kour Nangra, vice-president, research, Angel Broking ...

  • Ranbaxy Laboratories sells Ranbaxy Vietnam Company Deal In Brief 3 Nov 2009 18:54 GMT
    ... Ranbaxy Laboratories sells Ranbaxy Vietnam Company Deal In Brief Nov 03, 2009 (Datamonitor Financial Deals ...

  • Dr Reddy's develops generic version of Pfizer's Lipitor 6 Nov 2009 22:22 GMT
    ... from next year. The only Indian company in the club so far has been Ranbaxy [ Dr Reddy's Laboratories and its US subsidiary informed Pfizer last month about the ...

  • Cipher reports Q3 2009 financial results 4 Nov 2009 12:36 GMT
    ... of $0.2 million for Q3 2009 is net of reimbursements of $0.3 million from Ranbaxy related to the CIP-ISOTRETINOIN clinical study. Operating, General and Administrative ("OG&A") expenses for Q3 ...

  • New tonic for Revital 2 Nov 2009 06:51 GMT
    ... Ranbaxy executives say Revital is among the most preferred 'daily health supplements' and one of ...

  • David Pilling: Roll up for Japan's medical mystery tour 5 Nov 2009 07:30 GMT
    ... they manage them. So far, the omens are not great. Daiichi Sankyo’s purchase of Ranbaxy – described by independent consultant Pelham Smithers as “right idea, wrong price” – was ...

  • Skindia GDR Index down 0.08% 5 Nov 2009 12:41 GMT
    ... main gainers were GAIL (+4.55%; weight 1.58%), Mahindra & Mahindra (+4.08%; weight 2.22%) and Ranbaxy (+1.99%; weight 0.51%) and the main losers were ITC (-3.32%; weight 0.84%), L & ...

  • Public spending on healthcare should be raised 3 Nov 2009 11:18 GMT
    ... also quite clear that some of these deals, like the most celebrated one of Ranbaxy [ ] going to its Japanese acquirer Daiichi Sankyo, have been very attractively priced. ...

  • Public spending on healthcare... 3 Nov 2009 12:37 GMT
    ... also quite clear that some of these deals, like the most celebrated one of Ranbaxy [ ] going to its Japanese acquirer Daiichi Sankyo, have been very attractively priced. ...

  • Skindia GDR Index down 1.61% 3 Nov 2009 12:31 GMT
    ... Skindia GDR Index, two were up and six were down. The two gainers were Ranbaxy (+4.46%; weight 0.54%) and ITC (+0.18%; weight 27.11%) and the main losers were GAIL ...

  • The Chindia trade solution 3 Nov 2009 16:56 GMT
    ... Services and Satyam already have operations in China, as do pharmaceutical firms such as Ranbaxy and Dr Reddy’s Laboratories. Supply chains are now more likely than ever to run ...

  • Research and Markets: This Essential Q4 2009 South Africa Pharmaceuticals and Healthcare Report Provides Independent Forecasts and Competitive Intelligence on the Industry 6 Nov 2009 11:31 GMT
    ... BMI's Forecast Scenario -- Leading Foreign Companies -- Sanofi-Aventis -- Pfizer -- Roche -- Ranbaxy -- GlaxoSmithKline -- Merck & Co -- Leading Indigenous Manufacturers -- Aspen Pharmacare -- ...


1 - 15 / 80      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS RANBAXY NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.